Press Releases

Cardiologists at the University of Rochester Medical Center are launching a new study in an effort to improve the treatment of a very common form of heart disease in the Asian population.

As randomized controlled trials and systematic reviews in healthcare have grown in their number and influence, there is an increasing need to identify those studies which should change how physicians treat their patients – and those which should not. F1000Trials extends the widely-recognized system of peer-nominated experts identifying great research in biology and medicine pioneered by F1000Prime. In F1000Trials, the F1000 Faculty Members provide expert assessment of newly published trial articles and write short reviews, recommending the most noteworthy by assigning star ratings and highlighting those which change clinical practice.

The Texas Council on Cardiovascular Disease (CVD) and Stroke, in conjunction with the CVD & Stroke Program of the Texas Department of State Health Services, will present Healthy Lubbock with the Department of State Health Services 2013 Cardiovascular Health Promotions Award.

Nicolas Chronos, MD has been named Chief Medical Officer for Endotronix.  Dr. Chronos is an interventional cardiologist who is well known for his pioneering research in the treatment of heart disease. 

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced that its subsidiary Hotspur Technologies, Inc., which Teleflex acquired in June 2012, received FDA 510(k) clearance to market the company’s ARROW® GPSCath® Balloon Dilatation Catheters in Higher Rated Burst Pressure (RBP) and 80 cm lengths. These novel products enable multiple vascular procedures to be performed with one dual-function catheter, potentially reducing procedure time and expense for both patients and medical professionals.

eCardio Diagnostics, a leader in remote arrhythmia monitoring services, has promoted John H. Untereker to President, effective immediately. He will remain COO.

Providing hospitals with resources to expand or create education and patient care initiatives, AHRA: The Association for Medical Imaging Management announces the sixth year of its Putting Patients First Program. Putting Patients First grants enable healthcare facilities to fund programs, training or seminars aimed at improving patient care and safety in CT, MR, Ultrasound, X-ray and Vascular imaging. The grants are funded by an unrestricted educational grant from Toshiba America Medical Systems, Inc.

The Accreditation for Cardiovascular Excellence (ACE) announced this week that updated standards for cardiac intervention procedures have been published and are now available for download on the ACE website. ACE updated its Cath/PCI standards to align with the recently published clinical competency document for PCI which includes information on physician training, clinical competency criteria and the updated expert consensus document published in 2012.

Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rhythmia™ Mapping System, a next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology (EP) procedures to diagnose or treat a variety of conditions in which the heart beats abnormally.

The University of Vermont College of Medicine has announced that cardiologist and Professor of Medicine David Schneider, M.D., has been appointed director of the Cardiovascular Research Institute (CVRI). The director of cardiology in the department of medicine and medical director of cardiology at Fletcher Allen Health Care, Schneider will succeed CVRI founding director Burton Sobel, M.D., who passed away in spring 2013.

JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease, announced today that it has raised $62.5 million in a Series C venture round.

Through the kindness of Richard M. and Yvonne Hamlin, Summa Health System announced today the largest philanthropic gift in its organization’s history – a $4 million contribution for the creation of a hybrid cardiovascular operating room at Summa Akron City Hospital. In honor of the benefactors, Summa’s Center of Excellence building at 95 Arch Street in Akron will be renamed The Richard M. and Yvonne Hamlin Pavilion. The facility is home to numerous cardiopulmonary patient services as well as medical and surgical physician offices.

To improve clinical staff safety during interventional procedures and help monitor radiation dose, Toshiba America Medical Systems, Inc. has partnered with Unfors RaySafe, Inc. to offer a new dose monitoring and management tool for Infinix™-i cardiovascular X-ray systems. The Unfors RaySafe i2 displays real-time dose exposure information, helping to make exams safer for all clinical staff.

A new book, The Heart of Leonardo, features all of Leonardo's drawings on the heart and its physiology, accompanied by translations of his accompanying notes.

Ipsos Healthcare, the global healthcare division of Ipsos, has added the Stroke Prevention in Atrial Fibrillation (SPAF) Monitor to its syndicated Cardiovascular Therapy Monitor Portfolio.

The Society of Cardiovascular Computed Tomography (SCCT) has honored Valentin Fuster, MD, PhD, Director of Mount Sinai Heart at The Mount Sinai Medical Center, with the 2013 SCCT Arthur S. Agatston Cardiovascular Disease Prevention Award at its SCCT Annual Scientific Meeting in Montréal, Canada, on July 12. 

Enhancing its product leadership team, Toshiba America Medical Systems, Inc. has named David Sloop director, X-ray Vascular Business Unit. Sloop will be responsible for implementing strategic marketing plans to drive growth and profitability of Toshiba’s X-ray Vascular product line.

Royal Philips today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its innovative AlluraClarity live image guidance system in the US. 

The American Association of Clinical Endocrinologists (AACE) today announced the online publication of the organization’s comprehensive diabetes management algorithm consensus statement.

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla™ Guide Extension Catheter and has launched the device in the U.S. and Europe.

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), announced today that it received approval from its European Notified Body to expand the CE Mark indications of the Self-Apposing stent.